During a surgery, how do surgeons control excessive bleeding, especially in a heart surgery?

Surgeons use clamps, stitches, suction, staples and glue to stop bleeding





NEW FIBRIN SEALANT APPROVED TO HELP CONTROL BLEEDING IN SURGERY





FDA today approved the first of a new class of commercially available blood-derived products called fibrin sealants that are applied topically to help control bleeding. Fibrin sealants can be used to stop oozing from small, sometimes inaccessible, blood vessels during surgery when conventional surgical techniques are not feasible. The product is effective for use in cardiopulmonary bypass and colostomy operations and also in situations when a traumatic injury to the spleen has occurred.


The main active ingredient of fibrin sealant is fibrinogen, a protein from human blood that forms a clot when combined with thrombin -- another blood protein that facilitates blood clotting. The product works by forming a flexible material over the oozing blood vessel that can often control bleeding within five minutes.





Although many surgeons have legally prepared their own fibrin sealants, these locally prepared products are not standardized or consistent, and the available sources of fibrinogen are not virally inactivated.





This product is manufactured by Oesterreichisches Institut Fuer Haemoderivate G.M.B.H. in Vienna, Austria and distributed by Baxter Healthcare Corporation, Glendale, Calif. under the brand name TISSEEL.

During a surgery, how do surgeons control excessive bleeding, especially in a heart surgery?
Years of training